There are 2867 resources available
1516P - Diagnostic delay due to COVID-19 pandemic in sarcoma patients: Single-centre retrospective SarCorD study (COMETA Project)
Presenter: Antonella Cosimati
Session: Poster session 11
1517P - Role of geriatric assessment and oncological multidimensional prognostic index (onco-MPI) in older patients (age ≥70 years) with advanced soft tissue sarcoma in a real-world setting
Presenter: BENEDETTA CHIUSOLE
Session: Poster session 11
833P - Longer follow up of a real-world study of cemiplimab in advanced cutaneous squamous cell carcinoma: Focus on late toxicities and long term benefit
Presenter: Pietro Quaglino
Session: Poster session 03
1518P - An individualized model-based risk score is the best prognostic tool for localized soft tissue sarcoma (STS) cases, but clinical status cannot be neglected
Presenter: Pawel Teterycz
Session: Poster session 11
1106P - Capmatinib for METex14 non-small cell lung cancer patients: Results of the real-world study IFCT-2104 CapmATU
Presenter: Marion Ferreira
Session: Poster session 15
834P - Intracranial disease control and survival in patients with melanoma brain metastases (MBM) treated with radiation and immune checkpoint inhibitors (IO)
Presenter: Mauricio Fernando Silva Almeida Ribeiro
Session: Poster session 03
1520P - Preferences on treatment decision making in sarcoma patients. Prevalence and associated factors: Results from the PROSa study
Presenter: Hanna Salm
Session: Poster session 11
1107P - BRAF mutations and fusions in a real-world cohort of NSCLC patients
Presenter: Jiaxin Niu
Session: Poster session 15
835P - Efficacy of checkpoint inhibitors and targeted therapy depending on the line of treatment in patients with advanced / metastatic melanoma
Presenter: Bozena Cybulska-Stopa
Session: Poster session 03